It may be rational for the physicians to monitor these drugs frequently, even if monitoring is not needed, to make sure that the patient is compliant.

A new class of anticoagulant drugs on the horizon is taking fresh aim at one of cardiology’s toughest challenges: how to prevent blood clots that cause heart attacks and strokes, without leaving ...

“There is something [going on] between cognitive decline and atrial fibrillation, even if you're young and without any risk ...

Triple therapy was a combination of aspirin, thienopyridine and warfarin. ACS: Acute coronary syndrome; AF: Atrial fibrillation; Asa: Aspirin; BMS: Bare-metal stent ...

Tom Nolan reviews this week’s research Trials of direct oral anticoagulants for atrial fibrillation have excluded patients with acute ischaemic stroke because of concerns over the risk of haemorrhagic ...

It is well-tolerated and facilitates the early restart of anticoagulation following a ... that it has received approval from Central Drugs Standard Control Organisation (CDSCO) in India for ...

Warfarin is an anticoagulation drug that is used in the prevention of thrombosis. It functions to decrease blood coagulation by inhibiting vitamin K epoxide reductase, thus antagonizing vitamin K1 ...

a clinical-stage novel cardiorenal therapy with orphan drug designation. (PRNewsfoto/Cadrenal Therapeutics, Inc.) The AC Forum is the largest professional organization of anticoagulation ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

The company has engaged with healthcare professionals at major conferences, confirming the demand for alternatives to current anticoagulants and validating ... endpoints that will further assess the ...

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and ...